NCT02729532View on ClinicalTrials.gov

Effect of Xpert MTB/RIF on Patient Outcomes

CompletedOBSERVATIONAL
Enrollment

776

Participants

Timeline

Start Date

June 22, 2016

Primary Completion Date

February 9, 2018

Study Completion Date

February 9, 2018

Conditions
Tuberculosis
Interventions
DEVICE

Xpert

The Xpert MTB/RIF assay is a nucleic acid amplification (NAA) test that uses a disposable cartridge with the GeneXpert Instrument System

Trial Locations (1)

Unknown

Chelstone and Chilenje Health Centres, Lusaka

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT02729532 - Effect of Xpert MTB/RIF on Patient Outcomes | Biotech Hunter | Biotech Hunter